Roche Glycart Company
Roche Glycart is a company that creates antibody drugs such as GA101 and GA201. GA101 is a monoclonal antibody that targets CD20 to increase cell death, while GA201 is an antibody designed for solid tumors.
Roche Glycart is a company that creates antibody drugs such as GA101 and GA201. GA101 is a monoclonal antibody that targets CD20 to increase cell death, while GA201 is an antibody designed for solid tumors.
